These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22097686)

  • 1. Critical evaluation of the optimal medical therapy in the cardiac resynchronization therapy candidates--single centre experience.
    Vondráková D; Málek F; Dvorák J; Sedivá L; Kupec J; Petrů J; Táborský M; Neuzil P
    Vnitr Lek; 2011 Oct; 57(10):799-802. PubMed ID: 22097686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy allows the optimization of medical treatment in heart failure patients.
    Kachboura S; Ben Halima A; Ibn Elhadj Z; Marrakchi S; Chrigui R; Kammoun I; Chine S; Lefi A
    Ann Cardiol Angeiol (Paris); 2014 Feb; 63(1):17-22. PubMed ID: 23932251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.
    Schmidt S; Hürlimann D; Starck CT; Hindricks G; Lüscher TF; Ruschitzka F; Steffel J
    Eur Heart J; 2014 Apr; 35(16):1051-60. PubMed ID: 24371079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
    Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
    Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
    Eur Heart J Cardiovasc Pharmacother; 2015 Jul; 1(3):182-8. PubMed ID: 27533993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjustments of heart failure medication after implantation of a cardiac resynchronization therapy defibrillator.
    Hitz L; Kühne MS; Sticherling C; Osswald S; Schaer BA
    Minerva Med; 2012 Oct; 103(5):361-7. PubMed ID: 23042371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis.
    Mantziari L; Guha K; Khalique Z; McDonagh T; Sharma R
    Am J Cardiol; 2012 Jun; 109(11):1619-25. PubMed ID: 22465318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].
    MMW Fortschr Med; 2002 Nov; 144(45):58. PubMed ID: 12534067
    [No Abstract]   [Full Text] [Related]  

  • 15. Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures.
    Hauptman PJ; Swindle JP; Masoudi FA; Burroughs TE
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):204-11. PubMed ID: 20197509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
    Shimamoto K; Kawana M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():531-6. PubMed ID: 17511104
    [No Abstract]   [Full Text] [Related]  

  • 18. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
    Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA
    JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure treatment profile at the beta blockers era.
    Silva CP; Bacal F; Pires PV; Mangini S; Issa VS; Moreira SF; Chizzola PR; Souza GE; Guimarães GV; Bocchi EA
    Arq Bras Cardiol; 2007 Apr; 88(4):475-9. PubMed ID: 17546280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality of life in patients after anti-arrhythmic devices implantation].
    Lełakowska-Piela M; Pudło J; Rydlewska A; Senderek T; Lelakowski J
    Pol Merkur Lekarski; 2013 Dec; 35(210):331-8. PubMed ID: 24490461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.